文献速递呼吸道感染呼吸危重症与机械通气

低风险SARS-CoV-2肺炎的早期识别:基于入院数据与IDSA/ATS次要标准的验证模型

Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria.
PubMed 文献 · Chest · 2022-05-21

该多中心队列研究纳入推导队列1,274例及两个验证队列830例和754例住院SARS-CoV-2肺炎患者,通过多项式回归识别低风险(未死亡且未需ICU)的独立预测因素,包括SpO2/FiO2>450、IDSA/ATS次要标准<3条、淋巴细胞计数>723 cells/mL、尿素<40 mg/dL和CRP<60 mg/L,模型AUC在推导队列为0.802,验证队列分别为0.779和0.801。

要点

  • 入院时SpO2/FiO2>450、IDSA/ATS次要标准<3条等5项指标可识别低风险SARS-CoV-2肺炎。
  • 模型在推导队列AUC为0.802,两个验证队列分别为0.779和0.801。
  • 低风险患者约占住院SARS-CoV-2肺炎患者的80%,有助于优化医疗资源分配。

核心结论

  • 入院初始生化指标及IDSA/ATS次要标准<3条可早期识别约80%住院SARS-CoV-2肺炎低风险患者。

研究设计与样本

  • 多中心队列研究,推导队列1,274例,验证队列包括第一波830例和第二波754例住院SARS-CoV-2肺炎患者。
  • 采用多项式回归分析比较病房收治(低风险)、直接ICU、病房转ICU及死亡患者,并识别低风险独立因素后验证模型。

主要发现

  • 直接入ICU、病房转ICU及死亡患者特征相似,可合并为一组。
  • 低风险独立预测因素(OR,95%CI):SpO2/FiO2>450(0.233;0.149-0.364);IDSA/ATS次要标准<3条(0.231;0.146-0.365);淋巴细胞计数>723 cells/mL(0.539;0.360-0.806);尿素<40 mg/dL(0.651;0.426-0.996);CRP<60 mg/L(0.454;0.285-0.724)。
  • 模型AUC:推导队列0.802(0.769-0.835);验证队列第一波0.779(0.742-0.816),第二波0.801(0.757-0.845)。

关键数值与推荐

  • 低风险预测因素阈值:SpO2/FiO2>450、IDSA/ATS次要标准<3条、淋巴细胞计数>723 cells/mL、尿素<40 mg/dL、CRP<60 mg/L。
  • 低风险定义为未死亡且未需ICU入住。

临床怎么用

  • 入院时应用上述5项指标可快速识别低风险SARS-CoV-2肺炎患者,辅助分流至普通病房。
  • 该模型有助于精简医疗资源分配,缓解ICU和普通病房床位压力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A shortage of beds in ICUs and conventional wards during the COVID-19 pandemic led to a collapse of health care resources. RESEARCH QUESTION: Can admission data and minor criteria by the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) help identify patients with low-risk SARS-CoV-2 pneumonia? STUDY DESIGN AND METHODS: This multicenter cohort study included 1,274 patients in a derivation cohort and 830 (first wave) and 754 (second wave) patients in two validation cohorts. A multinomial regression analysis was performed on the derivation cohort to compare the following patients: those admitted to the ward (assessed as low risk); those admitted to the ICU directly; those transferred to the ICU after general ward admission; and those who died. A regression analysis identified independent factors for low-risk pneumonia. The model was subsequently validated. RESULTS: In the derivation cohort, similarities existed among those either directly admitted or transferred to the ICU and those who died. These patients could, therefore, be merged into one group. Five independently associated factors were identified as being predictors of low risk (not dying and/or requiring ICU admission) (ORs, with 95% CIs): peripheral blood oxygen saturation/Fio2 > 450 (0.233; 0.149-0.364); < 3 IDSA/ATS minor criteria (0.231; 0.146-0.365); lymphocyte count > 723 cells/mL (0.539; 0.360-0.806); urea level < 40 mg/dL (0.651; 0.426-0.996); and C-reactive protein level < 60 mg/L (0.454; 0.285-0.724). The areas under the curve were 0.802 (0.769-0.835) in the derivation cohort, and 0.779 (0.742-0.816) and 0.801 (0.757-0.845) for the validation cohorts (first and second waves, respectively). INTERPRETATION: Initial biochemical findings and the application of < 3 IDSA/ATS minor criteria make early identification of low-risk SARS-CoV-2 pneumonia (approximately 80% of hospitalized patients) feasible. This scenario could facilitate and streamline health care resource allocation for patients with COVID-19.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Menéndez R, Méndez R, González-Jiménez P, et al. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria. Chest. 2022. PMID: 35609674. doi:10.1016/j.chest.2022.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。